2016 Hematological Malignancies

1777 / 1835

Enter answer text...Enter answer text...Enter answer text...Enter answer text...
0% 0% 0% 0%
Further therapy needed?
A. No (just
observation)
B. Brentuximab
Vedotin
C. Anti-PD1